Recent Publications:

Preferential expansion of pro-inflammatory Tregs in human non-small cell lung cancer.

Phillips JD, Knab LM, Blatner NR, Haghi L, DeCamp MM, Meyerson SL, Heiferman MJ, Heiferman JR, Gounari F, Bentrem DJ, Khazaie K.

Cancer Immunol Immunother. 2015 Jun 6

Factors affecting selection of operative approach and subsequent short-term outcomes after anatomic resection for lung cancer.

Phillips JD, Merkow RP, Sherman KL, DeCamp MM, Bentrem DJ, Bilimoria KY.

J Am Coll Surg. 2012 Aug;215(2):206-15

Zileuton, 5-lipoxygenase inhibitor, acts as a chemopreventive agent in intestinal polyposis, by modulating polyp and systemic inflammation.

Gounaris E, Heiferman MJ, Heiferman JR, Shrivastav M, Vitello D, Blatner NR, Knab LM, Phillips JD, Cheon EC, Grippo PJ, Khazaie K, Munshi HG, Bentrem DJ.

PLoS One. 2015 Mar 6;10(3):e0121402

Expression of RORγt marks a pathogenic regulatory T cell subset in human colon cancer.

Blatner NR, Mulcahy MF, Dennis KL, Scholtens D, Bentrem DJ, Phillips JD, Ham S, Sandall BP, Khan MW, Mahvi DM, Halverson AL, Stryker SJ, Boller AM, Singal A, Sneed RK, Sarraj B, Ansari MJ, Oft M, Iwakura Y, Zhou L, Bonertz A, Beckhove P, Gounari F, Khazaie K.

Sci Transl Med. 2012 Dec 12;4(164):164ra159

Short-term outcomes after esophagectomy at 164 American College of Surgeons National Surgical Quality Improvement Program hospitals: effect of operative approach and hospital-level variation.

Merkow RP, Bilimoria KY, McCarter MD, Phillips JD, DeCamp MM, Sherman KL, Ko CY, Bentrem DJ.

Arch Surg. 2012 Nov;147(11):1009-16.